Doxa AB
STO:DOXA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.01
3.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DOXA stock under the Base Case scenario is 0.75 SEK. Compared to the current market price of 1.018 SEK, Doxa AB is Overvalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Doxa AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DOXA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Doxa AB
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Doxa AB
Balance Sheet Decomposition
Doxa AB
Current Assets | 35.5m |
Cash & Short-Term Investments | 11.8m |
Receivables | 23.7m |
Non-Current Assets | 3.5B |
Long-Term Investments | 2.2B |
PP&E | 6.3m |
Other Non-Current Assets | 1.3B |
Current Liabilities | 228.1m |
Other Current Liabilities | 228.1m |
Non-Current Liabilities | 157.8m |
Other Non-Current Liabilities | 157.8m |
Earnings Waterfall
Doxa AB
Revenue
|
16.8m
SEK
|
Cost of Revenue
|
-5.1m
SEK
|
Gross Profit
|
11.7m
SEK
|
Operating Expenses
|
-19.2m
SEK
|
Operating Income
|
-7.5m
SEK
|
Other Expenses
|
-200.7m
SEK
|
Net Income
|
-208.2m
SEK
|
Free Cash Flow Analysis
Doxa AB
SEK | |
Free Cash Flow | SEK |
DOXA Profitability Score
Profitability Due Diligence
Doxa AB's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
Score
Doxa AB's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
DOXA Solvency Score
Solvency Due Diligence
Doxa AB's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Doxa AB's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DOXA Price Targets Summary
Doxa AB
Dividends
Current shareholder yield for DOXA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
DOXA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
Contact
IPO
Employees
Officers
The intrinsic value of one DOXA stock under the Base Case scenario is 0.75 SEK.
Compared to the current market price of 1.018 SEK, Doxa AB is Overvalued by 26%.